Health Insurance (Variation of Pathology Services Table) (No. 2) Regulations (Cth)

Statutory Rules 1990 No. 3121

–––––––

Health Insurance (Variation of Pathology Services Table) (No. 2) Regulations

I, THE GOVERNOR-GENERAL of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Health Insurance Act 1973.

Dated 11 October 1990.

BILL HAYDEN

Governor-General

By His Excellency’s Command,

B. HOWE

Minister of State for Community Services and Health

–––––––––

Citation

1. These Regulations may be cited as the Health Insurance (Variation of Pathology Services Table) (No. 2) Regulations.

Commencement

2. These Regulations commence on 15 October 1990.

 

Variation of the pathology services table

3. The Health Insurance Act 1973 has effect as if the pathology services table were varied:

(a) by inserting after rule 16 of the rules for interpretation the following heading:

 “PATHOLOGY SERVICES TABLE—SCHEDULE OF SERVICES AND FEES”;

(b) by omitting items 1396, 1397 and 2400;

(c) as the case requires:

(i) by substituting for the like-numbered item; or

(ii) inserting in the proper numerical position (in the case of item 2387, in Division 8);

each of the items set out in Schedule 1 to these Regulations;

(d) by omitting the lists of abbreviations and substituting the lists of abbreviations set out in Schedule 2 to these Regulations.

Repeal

4. Statutory Rules 1989 No. 198 and 1990 No. 84 are repealed.

––––––––––

SCHEDULE 1 Paragraph 4 (c)

ITEMS TO BE SUBSTITUTED FOR EXISTING ITEMS, OR INSERTED, IN THE PATHOLOGY SERVICES TABLE

Item No.	Pathology Service	Fees— All States
$
1170	Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services—Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, chloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1419. SP	13.20
1171	Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and if performed, any of these additional services—Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, chloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1420. OP	9.90
1419	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examinations of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 1170 and 1172—one or more tests. SP	11.60
1420	Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examinations of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm’s test) including those services specified in items 1171 and 1173—one or more tests. OP	8.70
1575	Qualitative estimation by any method, except by reagent strip or dipstick of the following urine constituents—bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma—one or more estimations. SP	12.60

SCHEDULE 1—continued

Item No.	Pathology Service	Fees— All States
$
1576	Qualitative estimation by any method, except by reagent strip or dipstick of the following urine constituents—bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in plasma—one or more estimations. OP	9.45
1712	Drug assay—quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken—one estimation not elsewhere specified in the Schedule. SP	26.50
1713	Drug assay—quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken—one estimation not elsewhere specified in the Schedule. OP	19.90
1726	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid—one or more examinations or estimations. SP	42.00
1727	Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio, palmitic acid, phosphatidylglycerol or lamellar body phospholipid—one or more examinations or estimations. OP	31.50
1738	Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-l esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1752), Haptoglobins, Microalbumin (in proven diabetes mellitus), Mucin-like carcinoma associated antigen (one or more fractions), Prostate specific antigen, Prostatic Acid Phosphatase (one or more fractions), Transferrin (unless specified in item 1752), and, in the follow-up of proven malignancy, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin,—quantitative estimation in serum, urine or other body fluid—one estimation. SP	25.50

SCHEDULE 1—continued

Item No.	Pathology Service	Fees— All States
$
1739	Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-l esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1753), Haptoglobins, Microalbumin (in proven diabetes mellitus), Mucin-like carcinoma associated antigen (one or more fractions), Prostate specific antigen, Prostatic Acid Phosphatase (one or more fractions), Transferrin (unless specified in item 1753), and, in the follow-up of proven malignancy, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Mammary serum antigen, Neuron specific enolase, SCC Related antigen, Thyroglobulin,—quantitative estimation in serum, urine or other body fluid—one estimation. OP	19.15
1771	Red cell folate and serum B12 and, if required, serum folate, to a maximum of three estimations in any 12-month period. OP	43.15
1791	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, seratonin, xylose, zinc—one quantitative estimation. SP	31.50
1792	Acetoacetate, alcohol, aminoacids, ammonia, angiotensin converting enzyme, betahydroxybutyrate, cholinesterase, cystine (cysteine), histamine, hydroxyindoleacetic acid, hydroxyproline, lactate, neonatal bilirubin (one or more fractions), oxalate, pyruvate, seratonin, xylose, zinc—one quantitative estimation. OP	23.65
1959	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA)— quantitative including any qualitative estimations—one or more estimations. SP	51.00
1960	Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Metanephrines, Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA)— quantitative including any qualitative estimations—one or more estimations. OP	38.25

SCHEDULE 1—continued

Item No.	Pathology Service	Fees— All States
$
2021	Hormones and hormone binding proteins, qualitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth Hormone, Medroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone)—one estimation. SP	36.50
2024	Hormones and hormone binding proteins, qualitative estimation by any method of: ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, 11-Deoxycortisol, Dihydrotestosterone, FSH, Gastrin, Glucagon, Growth Hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, TSH (where not requested as part of a thyroid function test), Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti-diuretic hormone)—one estimation. OP	27.40
2032	Five estimations specified in item 2024. OP	75.00
2087	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any additional services specified in item 2083—one or more sites. SP	25.00
2088	The cultural examination and microscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any additional services specified in item 2084—one or more sites. OP	18.75
2089	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following—skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens) or specimens of sputum (except when part of item 2119), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 2083 and 2087—one or more examinations on one or more specimens. SP	36.50

SCHEDULE 1—continued

Item No.	Pathology Service	Fees— All States
$
2090	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following: skin or other superficial sites, urethra, vagina, cervix or rectum (except for faecal pathogens) or specimens of sputum (except when part of item 2120), including pathogenic identification and antibiotic sensitivity testing, including any services specified in items 2084 and 2088—one or more examinations on one or more specimens. OP	27.40
2098	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 2083, 2087 anti 2089—one or more sites. SP	49.50
2099	Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of postoperative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in items 2084, 2088 and 2090—one or more sites. OP	37.15
2229	All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 2221, 2223 and 2231. SP	47.50
2230	All serological tests performed for the identification of the agent causing acute Hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core antibody and Hepatitis A IgM antibody tests and those services specified in items 2222, 2224 and 2232. OP	35.65
2258	Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any 12-month period. OP	25.15
2261	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required. SP	31.50
2262	Antinuclear antibodies, detection in serum or other body fluids, including quantitation if required. OP	23.65

SCHEDULE 1—continued

Item No.	Pathology Service	Fees— All States
$
2263	Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method) performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained. SP	38.50
2266	Measurement of DNA binding (by Farr or equivalent assay, but excluding the Crithidia method) performed only where a positive antinuclear antibody titre of 1:40 or greater has been obtained. OP	28.85
2315	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1—Haematology in the Schedule. SP	66.00
2316	Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar) and any test specified in Division 1—Haematology in the Schedule. OP	49.50
2343	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2340 and any histopathology service performed on that cytology specimen—one or more examinations. SP	38.00
2344	Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine (single specimen), washings or brushings not specified in item 2341 and any histopathology service performed on that cytology specimen—one or more examinations. OP	28.50
2355	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. SP	89.00
2356	Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist; or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. OP	66.75
2387	Seminal examination for presence of spermatozoa.	5.85
2396	Microscopical examination of gram-stained film.	7.40
2397	Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method.	1.95

––––––––––

SCHEDULE 2 Paragraph 4 (d)

LISTS OF ABBREVIATIONS

A. ABBREVIATIONS FOR GROUPS OF TESTS

Group	Estimations Included in Group	Abbreviation	Item Numbers
Cardiac Enzymes	Lactate dehydrogenase (LDH) Aspartate aminotransferase (AST) and Creatine kinase (CK)	CE	1562, 1563
Coagulation Studies	Prothrombin Time, activated partial thromboplastin time and 2 or more of the following tests: bleeding time, thrombin clotting time, fibrinogen degradation products, fibrin monomer, D-dimer, Factor XIII screening tests.	COAG	1527, 1528
Electrolytes	Sodium (NA), Potassium (K), Chloride (CL) and Bicarbonate (HC03)	E	1564, 1565
Lipid Studies	Cholesterol (CHOL) and Triglycerides (TRIG)	FATS	1560, 1561
Liver Function Tests	Alkaline phosphatase (ALP),  Alanine aminotransferase (ALT), Aspartate aminotransferase (AST) Albumin (ALB), Bilirubin (BIL), Gamma glutamyl  transpeptidase (GGT), Lactate dehydrogenase (LDH) and Protein (PROT)	LFT	1571, 1572
Syphilis Serology	Rapid plasma reagin test (RPR) or venereal disease research laboratory test (VDRL) and Treponema pallidum haemagglutin test (TPHA) or Fluorescent Treponemal antibody-absorption test (FTA)	STS	2183, 2184

 

SCHEDULE 2—continued

B. ABBREVIATIONS FOR INDIVIDUAL TESTS

The abbreviations are listed alphabetically within the following Divisions:

1. HAEMATOLOGY

2. CHEMICAL PATHOLOGY

3. MICROBIOLOGY

4. IMMUNOLOGY

5. HISTOPATHOLOGY

6. CYTOPATHOLOGY

7. CYTOGENETICS

8. INFERTILITY & PREGNANCY TESTS

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
DIVISION 1—HAEMATOLOGY
Antithrombin III	ATH	1531, 1532
Abnormal haemoglobins—spectroscopic examination of blood	AH	1419, 1420
Bleeding Time	BT	1521, 1522
Blood coagulation factors—quantitative assays:
Von Willebrand’s factor antigen	VWA	1541, 1542
Von Willebrand’s factor	VWF	1541, 1542
Fletcher Factor	FF	1541, 1542
Fitzgerald Factor	FGF	1541, 1542
Passovy Factor	PF	1541, 1542
Factor II	FII	1541, 1542
Factor V	FV	1541, 1542
Factor VII	FVII	1541, 1542
Factor VIII	FVIII	1541, 1542
Factor IX	FIX	1541, 1542
Factor X	FX	1541, 1542
Factor XI	FXI	1541, 1542
Factor XII	FXII	1541, 1542
Factor XIII	FXIII	1541, 1542
Blood Film	BF	1170, 1171
Blood Group Antibodies	BGA	1417, 1418
Blood Grouping—ABO and Rh (D antigen)	BG	1187, 1188
Blood Group and blood group antibodies (group and hold)	BGAB	1196, 1197
	Blood Group Systems (Duffy, Kell, M & N factors, Rh phenotypes)	BGS	1192, 1193
Bone Marrow Examination—Trephine		BMET	1181, 1182
Bone Marrow Examination—Aspirate	BMEA	1183, 1184
Carboxyhaemaglobin	COHB	1419, 1420
Coagulation Time	CT	1521, 1522
Cold Agglutinins	CAG	1419, 1420
Compatibility testing	XMAT	1198, 1199
C-reactive protein	CRP	1163, 1164
Differential Cell Count	DIFF	1170, 1171
Direct Coombs test	CMBS	1419, 1420
D-dimer test	DD	1521, 1522
Erythrocyte Count	RCC	1163, 1164
Erythrocyte Metabolic Enzymes	ERYM	1176, 1177
Erythrocyte Sedimentation Rate	ESR	1163, 1164

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Erythrocyte Haemolysis	ERYH	1176, 1177
Euglobulin clot lysis time	ECLT	1531, 1532
Fibrinogen Degradation Products	FDP	1521, 1522
Fibrin Monomer	FM	1521, 1522
Fibrinogen	FIB	1521, 1522
Full Blood Examination	FBE	1172, 1173
Haemoglobin Estimation	HB	1163, 1164
Haemoglobinopathy tests	HMGP	1179, 1180
Heparin Cofactor II	HRNC	1531, 1532
Heparin Estimation	HEPR	1539, 1540
Heterophile Antibodies (Infectious Mononucleosis Test)	IM	1419, 1420
Leucocyte Count	WCC	1163, 1164
Lupus Anticoagulant	LUPA	1531, 1532
Metalbumin detection (Schumm’s test)	SCHM	1419, 1420
Plasminogen	PLAS	1531, 1532
Partial Thromboplastin Time	PTT	1521, 1522
Platelet Aggregation

PLTG	1535, 1538
Platelet Count	PLTC	1163, 1164
Protein C	PROC	1531, 1532
Protein S	PROS	1531, 1532
Prothrombin Time	PT	1521, 1522
Red Cell Porphyrins—qualitative test	RCP	1419, 1420
Reticulocyte Count	RETC	1163, 1164
Test for Factor XIII Deficiency	F13D	1521, 1522
Thalassaemia Studies	TS	1179, 1180
Thrombin Time	TT	1521, 1522
Viscosity of blood or plasma	VISC	1163, 1164
DIVISION 2—CHEMICAL PATHOLOGY
Acetoacetate	ACAT	1791, 1792
Alanine Aminotransferase	ALT	1558, 1559
Albumin	ALB	1558, 1559
Alcohol (Ethanol)	ETOH	1791, 1792
Alkaline Phosphatase	ALP	1558, 1559
Alkaline Phosphatase Isoenzymes	ALPI	1734, 1735
Aminoacids	AMNA	1791, 1792
Amniotic Fluid Examination	AFE	1726, 1727
Ammonia	NH3	1791, 1792
Amylase	AMS	1558, 1559
Angiotensin converting enzyme	ACE	1791, 1792
Aspartate Aminotransferase	AST	1558, 1559
Beta Hydroxybutyrate	BHYB	1791, 1792
Bicarbonate	HCO3	1558, 1559
Bilirubin (all Fractions)	BILI	1558, 1559
Bilirubin (Neonatal)	BILN	1791, 1792
Blood Gases	GAS	1590, 1591
Calcium (total, dialysed or ionized)	CA	1558, 1559
Calculus Analysis	CALC	1595, 1596
Catecholamines	CAT	1959, 1960
Cholinesterase	CHSE	1791, 1792
Chloride	CL	1558, 1559

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Cholesterol	CHOL	1558, 1559
Cystine (Cysteine)	CYST	1791, 1792
Creatine Kinase	CK	1558, 1559
Creatine Kinase Isoenzymes	CKI	1558, 1559
Creatine Kinase Isoenzymes—Quantitative or Qualitative estimation by electrophoresis	CKIE	1734, 1735
Creatinine	C	1558, 1559
Cryoglobulins	CGLB	1575, 1576
Cryofibrinogen	CFIB	1575, 1576
Dexamethazone Suppression test	DEXA	2021, 2024
Drug or Chemical Assays—Overdose	DRGO	1598, 1599
Drug Assays—Drug abuse treatment programme including urinary drug screen	DRGA	1627, 1628
Drug Assays—Therapeutic:
Antibiotics or antimicrobial chemotherapeutic agents (see under MICROBIOLOGY)
Acetylated sulphadimidine	ASUL	1712, 1713
Amiodarone	AMIO	1712, 1713
Amitriptyline	AMIT	1712, 1713
Amylobarb	AMYL	1712, 1713
Barbitone	BARB	1712, 1713
Bromide	BRMD	1712, 1713
Butobarb	BUTO	1712, 1713
Carbamazepine (Tegretol)	CARB	1712, 1713
Chloral Hydrate	CHHY	1712, 1713
Chlorazepate	CHZP	1712, 1713
Chloropromazine	CHLO	1712, 1713
Chloroquine	CLOQ	1712, 1713
Cimetidine	CMTD	1712, 1713
Clobozam	CLOB	1712, 1713
Clonazepam (Rivotril)	CLON	1712, 1713
Cylosporin A	CLSA	1712, 1713
Desethyl Amiodarone	DEAM	1712, 1713
Desipramine	DESI	1712, 1713
Diazepam	DIAZ	1712, 1713
Digoxin	DIG	1712, 1713
Diphenylhydantoin (Dilantin)	DIL	1712, 1713
Disopyramide (Rythmodan)	DISO	1712, 1713
Doxepin	DOXE	1712, 1713
Ethosuximide (Zarontin)	ETHO	1712, 1713
Flecainide	FLEC	1712, 1713
Hydroxychloriquine	HOCQ	1712, 1713
Imipramine	IMIP	1712, 1713
Lignocaine	LIGN	1712, 1713
Methadone	MTDN	1712, 1713
Methotrexate	MTTA	1712, 1713
Methsuximide	MSUX	1712, 1713
Metronidazole	MRDZ	1712, 1713
Mexilitine (Mexitil)	MEX	1712, 1713
N Acetyl Procainamide	NAPC	1712, 1713
N Desalkyl Clobazan	NDAC	1712, 1713

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
N Desalkyldothiepin	NDOT	1712, 1713
N Desalkyl Doxepin	NDAD	1712, 1713
Nitrazepam	NITR	1712, 1713
Nordothiepin	NDIP	1712, 1713
Nortriptyline	NORT	1712, 1713
Oxazepam	OXAZ	1712, 1713
Paracetamol	PARA	1712, 1713
Paraquat	PARQ	1712, 1713
Pentabarb	PENT	1712, 1713
Perhexiline	PHEX	1712, 1713
Phenobarbitone	PHBA	1712, 1713
Phensoximide	PHEN	1712, 1713
Phenytoin	PHEY	1712, 1713
Prednisolone	PRED	1712, 1713
Primidone	PRIM	1712, 1713
Procainamide	PCAM	1712, 1713
Prominal	PROM	1712, 1713
Propanolol	PPNO	1712, 1713
Quinalbarb	QUIB	1712, 1713
Quinine	QNN	1712, 1713
Quinidine	QUIN	1712, 1713
Silicylate-Asprin	SALI	1712, 1713
Sotalol	SALL	1712, 1713
Stellazine	STEL	1712, 1713
Sulphadimidine	SPDD	1712, 1713
Sulthiame (Ospolot)	SUL	1712, 1713
Theophylline	THEO	1712, 1713
Thiopentone	TOPO	1712, 1713
Thioridazine	THIO	1712, 1713
Tocainide	TOCN	1712, 1713
Trimipramine	TRIM	1712, 1713
Valproate (Epilim)	VALP	1712, 1713
Vancomycin	VAN	1712, 1713
Warfarin	WFR	1712, 1713
Therapeutic drugs which are not listed above must be written in full
Electrophoresis
To demonstrate protein classes or presence and amount of paraprotein classes	EPP1	1734, 1735
To demonstrate protein classes or presence and amount of paraprotein classes—concurrent collection	EPP2	1736, 1737
Elements:
Aluminium	AL	1871, 1872
Arsenic	AS	1871, 1872
Beryllium	BE	1871, 1872
Cadmium	CD	1871, 1872
Chromium	CR	1871, 1872
Copper	CU	1871, 1872
Gold	AU	1871, 1872
Lead	PB	1895, 1896

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Manganese	MN	1871, 1872
Mercury	HG	1871, 1872
Nickel	NI	1871, 1872
Selenium	SE	1871, 1872
Strontium	SR	1871, 1872
Zinc	ZN	1791, 1792
Enzyme assays of solid tissue or tissues	ENZS	1969, 1970
Faecal Fat	FFAT	1963, 1964
Faecal Heamoglobin (chemical test)	FHC	1577, 1578
Faecal Heamoglobin (immunological test)	FHI	1579, 1580
Faecal Porphyrins (qualitative test)	FPR	1577, 1578
Faecal Reducing Substances	FRS	1577, 1578
Fructosamine	FRUC	1558, 1559
Gamma Glutamyl Transpeptidase	GGT	1558, 1559
Globulin	GLOB	1558, 1559
Glucose	GLUC	1558, 1559
Glucose Tolerance Test	GTT	1558, 1559
Glycosylated Haemoglobin (Hb Ale)	GHB	2043, 2044
HDL Cholesterol	HDLC	2039, 2040
Hormones:
Adrenocorticotrophic hormone	ACTH	2021, 2024
Aldosterone	ALDS	2021, 2024
Androstenedione	ANDR	2021, 2024
C-Peptide	CPEP	2021, 2024
Calcitonin	CALT	2021, 2024
Cortisol	CORT	2021, 2024
Cyclic AMP	CAMP	2021, 2024
Dehydroepiandrosterone sulphate	DHEA	2021, 2024
Dihydrotestosterone	DHTS	2021, 2024
Follicular Stimulating Hormone	FSH	2021, 2024
Gastrin	GAST	2021, 2024
Glucagon	GLGO	2021, 2024
Growth Hormone	GH	2021, 2024
Hormone Receptor Assay	HRA	2037, 2038
Hydroxyprogesterone	OHP	2021, 2024
Insulin	INS	2021, 2024
Luteinizing Hormone	LH	2021, 2024
Oestradiol	E2	2021, 2024
Oestriol	E3	2021, 2024
Oestrone	E1	2021, 2024
Parathyroid Hormone	PTH	2021, 2024
Progesterone	PROG	2021, 2024
Prolactin	PROL	2021, 2024
Renin	REN	2021, 2024
Sex Hormone Binding Globulin	SHBG	2021, 2024
Somatomedin	SOMA	2021, 2024
Testosterone	TES	2021, 2024
Thyroid Stimulating Hormone	TSH	2021, 2024
Urine Steroid Fraction or Fractions	USF	2021, 2024
Vasoactive Intestinal Peptide	VIP	2021, 2024
Vasopressin	ADH	2021, 2024
11 Deoxycortisol	DCOR	2021, 2024

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
HIAA (Hydroxyindoleacetic acid)	HIAA	1791, 1792
Histamine	HIAM	1791, 1792
HMMA (Hydroxy Methoxy Mandelic acid previously known as VMA)	HMMA	1959, 1960
HVA (Homovanillic acid)	HVA	1959, 1960
Hydroxyproline	HYDP	1791, 1792
Intestinal disaccharidases	INTD	1969, 1970
Iron Studies (Iron, Transferrin and Ferritin)	IS	1752, 1753
Lactate	LACT	1791, 1792
Lactate Dehydrogenase	LDH	1558, 1559
Lactate Dehydrogenase Isoenzymes	LDI	1734, 1735
Lamellar Body Phospholipid	LBPH	1726, 1727
Lecithin/Sphingomyelin Ratio (Amniotic fluid)	LS	1726, 1727
Lipase	LIP	1558, 1559
Lithium	LI	1558, 1559
Magnesium	MG	1558, 1559
Metanephrines	MNEP	1959, 1960
MHPG (Methoxy Hydroxy Phenyethylene Glycol)	MHPG	1959, 1960
Osmolality, Serum or Urine	OSML	1583, 1584
Oxalate	OXAL	1791, 1792
PAA (Phenyl Acetic Acid)	PAA	1959, 1960
Palmitic acid in amniotic fluid	PALM	1726, 1727
pH measurement of body fluids other than urine	PH	1575, 1576
Phosphate	PHOS	1558, 1559
Phosphatidylglycerol	PTGL	1726, 1727
Porphyrins (quantitative test, one or more fractions)	PR	1959, 1960
Potassium	K	1558, 1559
Protein (Total)	PROT	1558, 1559
Protein-Quantitative Estim. of Specific Protein:
Alpha feto protein	AFP	1738, 1739
Alpha-1 antitrypsin	AAT	1738, 1739
Alpha-2 macroglobulin	AMAC	1738, 1739
Beta-2 microglobulin	BMIC	1738, 1739
C-l esterase inhibitor	CEI	1738, 1739
Caeruloplasmin	CPLS	1738, 1739
Ferritin	FERR	1738, 1739
Haptoglobins	HGLB	1738, 1739
Microalbumin	MALB	1738, 1739
Transferrin	TRAN	1738, 1739
Pyruvate	PVTE	1791, 1792
Red Cell Folate and Serum B12 and, if required, Serum Folate	RCF	1770, 1771
Seratonin	SHT	1791, 1792
Serum B12	B12	1768, 1769
Serum Folate	FOL	1768, 1769
Snake Venom	HISS	1598, 1599
Sodium	NA	1558, 1559
Synacthen Stimulation Test	SYNS	2021, 2024
Thyroid Function Tests	TFT	1983, 1984

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Thyroid Stimulating Hormone (where not requested as part of a TFT)	TSH	2021, 2024
Thyrotrophin Releasing Hormone Test	TRH	1985, 1986
Triglycerides	TRIG	1558, 1559
Tumour Markers:
CA-125 antigen	C125	1738, 1739
CA-19.9 antigen	CA19	1738, 1739
CA-15.3 antigen	CA15	1738, 1739
Carcinoembryonic antigen	CEA	1738, 1739
Mammary Serum antigen	MSA	1738, 1739
Mucin-like carcinoma-associated antigen	MCA	1738, 1739
Neuron-specific enolase	NSEN	1738, 1739
Prostate-specific antigen	PSA	1738, 1739
Prostatic acid phosphatase—one or more fractions	ACP	1738, 1739
SCC-related antigen	SCCA	1738, 1739
Thyroglobulin	TGL	1738, 1739
Urate	URAT	1558, 1559
Urea	U	1558, 1559
Urine Bilirubin	UBIL	1575, 1576
Urine Cystine (Cysteine)	UCYS	1575, 1576
Urine Haemoglobin	UHB	1575, 1576
Urine Melanin (Melanogen)	UML	1575, 1576
Urine Myoglobin	UMY	1575, 1576
Urine Porphobilinogen	UPG	1575, 1576
Urine Porphyrins (qualitative test)	UPR	1575, 1576
Urine Urobilinogen	UUB	1575, 1576
Vitamin, Quantitative Estimation of Vitamins A, B1, B2, B3, B6, C or E	VIT	1780, 1783
Vitamin D	VITD	1786, 1787
Xylose	XYL	1791, 1792
DIVISION 3—MICROBIOLOGY
Antibiotic and antimicrobial chemotherapeutic agents, quantitative assay	QAA	2235, 2236
Blood Culture	BC	2123, 2124
Cultural Examination of faeces	FCS	2117, 2118
Herpes Simplex Virus Investigation by Cultural Methods	HSVC	2139, 2140
Chlamydia Investigation by Cultural Methods	CHLC	2139, 2140
Microbial Antibody Testing:
(IgG, IgM, IgA or Total antibodies may be tested against various organisms and are indicated by placing the letter G, M, A or T respectively on the end of the 3-letter abbreviation)
	Actinomycetes	ACT	2181, 2182
	Adenovirus	ADE	2181, 2182
	Aspergillus	ASP	2181, 2182
Avian precipitins (Bird Fancier’s Disease)	APP	2181, 2182
Blastomyces	BLM	2181, 2182
Bordetella pertussis	BOR	2181, 2182
Borrelia Berghoffer	BOB	2181, 2182
Brucella	BRU	2181, 2182

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Campylobacter Jejuni	CAM	2181, 2182
Candida	CAN	2181, 2182
Chlamydia	CHL	2181, 2182
Coccidioides	CCC	2181, 2182
Coxsackie Bl-6	COX	2181, 2182
Cryptococcus	CRY	2181, 2182
Cytomegalovirus	CMV	2181, 2182
Cytomegalovirus Serology in Pregnancy	CMVP	2145, 2146
Dengue	DEN	2181, 2182
Diphtheria	DIP	2181, 2182
Echinococcus	ECC	2181, 2182
Echo-coxsackie group	ECH	2181, 2182
Entamoeba histolytica	AMO	2181, 2182
Epstein Barr Virus	EBV	2181, 2182
Fluorescent Treponemal antibody—absorption test (FTA-ABS)	FTA	2181, 2182
Haemophilus	HUS	2181, 2182
Hepatitis delta antibody—Anti-delta	HDA	2181, 2182
Histoplasma	HIP	2181, 2182
Hydatid	HYD	2181, 2182
Influenza A	FLA	2181, 2182
Influenza B	FLB	2181, 2182
Legionella pneumophila—Serogroup 1	LP1	2181, 2182
Legionella pneumophila—Serogroup 2	LP2	2181, 2182
Leishmaniasis	LEI	2181, 2182
Leptospira	LEP	2181, 2182
Listeria	LIS	2181, 2182
Measles	MEA	2181, 2182
Micropolyspora faeni	MIC	2181, 2182
Mumps	MUM	2181, 2182
Murray Valley Encephalitis	MVE	2181, 2182
Mycoplasma pneumoniae	MYC	2181, 2182
Neisseria gonorrhoea	GON	2181, 2182
Newcastle Disease	NCD	2181, 2182
Parainfluenza 1	PF1	2181, 2182
Parainfluenza 2	PF2	2181, 2182
Parainfluenza 3	PF3	2181, 2182
Paratyphi	PTY	2181, 2182
Pertussis	PER	2181, 2182
Pneumococcus	PCC	2181, 2182
Poliomyelitis	PLO	2181, 2182
Proteus OX 19	POX	2181, 2182
Proteus OXK	POK	2181, 2182
Q fever	QFF	2181, 2182
Rapid Plasma Reagin test	RPR	2181, 2182
Respiratory Syncytial Virus	RSV	2181, 2182
Ross River Virus	RRV	2181, 2182
Rubella	RUB	2181, 2182
Rubella Serology in Pregnancy	RUBP	2145, 2146
Salmonella typhi (H)	SAH	2181, 2182
Salmonella typhi (O)	SAO	2181, 2182

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Schistosoma	STO	2181, 2182
Streptococcal Serology—Anti-D Nase B titre	ADNB	2181, 2182
Streptococcal Serology—Anti streptolysin O titre	ASOT	2181, 2182
Tetanus	TET	2181, 2182
Thermoactinomyces vulgaris	THE	2181, 2182
Thermopolyspora	TPS	2181, 2182
Toxocara	TOC	2181, 2182
Toxoplasma	TOX	2181, 2182
Toxoplasma Serology in Pregnancy	TOXP	2145, 2156
Treponema pallidum haemagglutin test	TPHA	2181, 2182
Trichonosis	TOS	2181, 2182
Typhus, Weil-Felix	TYP	2181, 2182
Venereal Disease Research Laboratory (VDRL)	VDRL	2181, 2182
Yersinia enterocolytica	YER	2181, 2182
Microbial antibody tests which are not listed above must be written in full
	Hepatitis Serology:
Hepatitis Serology in Acute Hepatitis	HEP	2229, 2230
Hepatitis B Serology in follow up of proven Hepatitis B Hepatitis B Surface antigen HBsAg	HEPB	2231, 2232
	HBSA	2221, 2222
Hepatitis B Serology to define immune status	HEPI	2223, 2224
Microbial Antigen Testing:
Chlamydia	CHLY	2133, 2134
Herpes Simplex Virus	HSV	2135, 2136
CSF antigens—Haemophilus influenzae, Streptococcus Pneumoniae, Neisseria Menigitidis, Group B Streptococcus	CSFA	2129, 2130
Cryptococcal antigen	CRYN	2129, 2130
RSV—Respiratory Syncytial Virus	RSVN	2129, 2130
Varicella Zoster	VCZN	2129, 2130
Microscopic examination of material other than blood	M	2083, 2084
Microscopic examination of faeces for parasites	OCP	2085, 2086
Microscopy and culture of material from nose, throat, eye and ear	MCS1	2087, 2088
Microscopy and culture of material from skin, superficial sites, urethra, vagina, cervix, sputum or rectum	MCS2	2089, 2090
Microscopy and culture of material from post-operative wounds, aspirations of body cavities, synovial fluid, CSF and operative or biopsy specimens	MCS3	2098, 2099
Microscopy and culture of sputum for mycobacteria	AFB	2119, 2120
Urine microscopy, culture, identification and sensitivity	UMCS	2127, 2128
DIVISION 4—IMMUNOLOGY
Specific IgG or IgE antibodies	ALLG	2259, 2260
Antibodies to Tissue Antigens:
Acetylcholine receptor	ARA	2271, 2274
Adrenal cell	ADR	2271, 2274
Cardiolipin	ACL	2271, 2274
Centromere	ACA	2271, 2274

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Gliad in IgA	GLIA	2271, 2274
Gastric parietal cell	PCA	2271, 2274
Glomerular basement membrane	GBA	2271, 2274
Insulin Receptor Antibodies	INSA	2271, 2274
Intercellular Cement Substance of skin	ICCS	2271, 2274
Jo-1	JO1	2271, 2274
Keratin	KERA	2271, 2274
Liver/Kidney microsomes	LKA	2271, 2274
Mitochondria	MA	2271, 2274
Parathyroid cell	PTHA	2271, 2274
PM-1	PM1	2271, 2274
Reticulin	RCA	2271, 2274
SCL 70	SCL	2271, 2274
Skeletal muscle	SLA	2271, 2274
Skin basement membrane	SKA	2271, 2274
Smooth muscle	SMA	2271,  2274
Thyroid microsomal	TMA	2271, 2274
TSH Receptor Antibody test	TSHA	2271, 2274
Tissue antigens which are not listed above must be written in full
Antibodies to Nuclear Antigens—detection	ANA	2261, 2262
Antibodies to Nuclear Antigens—quantitation and Measurement of DNA Binding if Positive ANA	ANAP	2263, 2266
Antibodies to Extractable Nuclear Antigens—detection	ENA	2267, 2268
Antibodies to Extractable Nuclear Antigens— characterization of antibodies if positive ENA	ENAP	2269, 2270
Complement Total, C3 or C4	COM	2289, 2290
Other complements must be specified
HLA Typing, comprising A, B, C and DR Phenotypes	HLA	2321, 2322
HLA Typing, one or more antigens	HLAN	2323, 2324
Immunoglobulins G, A, M or D	IG	2245, 2246
Immunoglobulin G, Subclasses 1-4	SIGG	2255, 2256
Immunoglobulin E	IGE	2257, 2258
Leucocyte Fractionation	LF.	2313, 2314
Leucocyte Functional Tests	LFF	2315, 2316
Leucocyte Surface Markers to assess lymphoid populations	LSML	2317, 2318
Leucocyte Surface Markers in investigation of probable haematological malignancy	LSMH	2319, 2320
Mantoux Test	MANT	2325, 2326
Paraprotein Investigation by Immuno-electrophoreses or immunofixation	PPRO	2239, 2240
Paraprotein Investigation on Concurrently Collected Serum and Urine	PPSU	2241, 2242
Rheumatoid Factor (all tests including Latex test)	RF	2281, 2282
Rheumatoid Factor quantitation	RFQ	2283, 2284
DIVISION 5—HISTOPATHOLOGY
Electron microscopy of biopsy material	EM	2333, 2337
Histopathology of biopsy material	HIST	2327, 2328
Immediate frozen section diagnosis of biopsy material	FS	2329, 2330

SCHEDULE 2—continued

Approved Item Name of Test in Schedule	Abbreviation	Item Numbers
Immunohistochemical investigation of biopsy material	IHIS	2331, 2332
DIVISION 6—CYTOPATHOLOGY
Cytology from cervix or vagina	CXCY	2338, 2339
Cytology from skin, nipple discharge, lip, mouth, nose or anus	SMCY	2340, 2341
Cytology from body fluids, sputum (1 specimen), washings or brushings	BFCY	2340, 2341
Cytology from 3 sputum or urine specimens	SPCY	2348, 2349
Cytology from fine needle aspiration of solid tissues	FNCY	2350, 2351
Cytology from fine needle aspiration of solid tissues— aspiration or attendance by Pathologist	FNCP	2355, 2356
DIVISION 7—CYTOGENETICS
Chromosome studies	CS	2360, 2361
Chromosome studies of blood	CSB	2363, 2364
Chromosome identification by banding techniques	CSI	2365, 2366
DIVISION 8—INFERTILITY AND PREGNANCY TESTS
Semen examination for spermatozoa	SES	2370, 2371
Huhner’s test	HT	2370, 2371
Semen examination	SEE	2372, 2373
Sperm antibodies	SAB	2377, 2378
Sperm penetrating ability	SPA	2377, 2378
Chorionic gonadotrophin for pregnancy diagnosis	HCG	2379, 2380
Chorionic gonadtrophin for diagnosis of specified conditions	HCGD	2384, 2385

NOTE

1. Notified in the Commonwealth of Australia Gazette